No Data
No Data
TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe
Stella Pharma: Confirmation letter
Stella Pharma: Half Year Report - Term 18 (2024/04/01 - 2025/03/31)
Stella Pharma: Supplemental financial results for the 2nd quarter of the fiscal year ending March 31, 2025
Stella Pharma: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending 2025/3 [Japanese GAAP] (unconsolidated)
Morinaga Milk, mcdonald's, Toyo Suisan, Eisai (8th) (1429-5463)
※Please note that the above calendar is tentative and subject to change based on the company's convenience. --------------------------------------- November 8th (Fri) <1429> Japan Aqua <1435> RoboHome <143A> Ishin <1450> Tanaka Construction Industry <1451> KHC <1518> Mitsui Matsushima HD <151A> Dai <167A> Ryo
No Data
No Data